市场调查报告书
商品编码
1494365
到 2030 年亚太地区呼吸分析仪市场预测 - 区域分析 - 按技术、应用和最终用户Asia Pacific Breath Analyzer Market Forecast to 2030 - Regional Analysis - By Technology, Application, and End User |
亚太呼吸分析仪市场预计将从2022年的2.3062亿美元成长到2030年的8.3477亿美元。
不断增长的酒精消费和酒精中毒事故推动了亚太呼吸分析仪市场
根据2022年发布的世界数据报告,全球人均酒精消费量为每人6.182公升。世界卫生组织(WHO)公布,每年过量饮酒导致300万人死亡(占全球总死亡人数的5.3%),对人们的福祉和健康造成损害。此外,全球因酒驾造成的疾病和伤害负担中的 5.1% 对个人和社会造成社会和经济损失。过量饮酒会导致道路交通事故和事故。
在澳大利亚,酒驾约占致命碰撞事故的 30%,死亡的驾驶和乘客中超过四分之一的血液酒精含量 (BAC) 水平超过允许限度。根据警方碰撞资料,大约三分之一的致命车祸是由超速造成的。 2021 年,有 163 人在道路重型车辆事故中丧生,占所有交通死亡人数的 15.4%。此外,根据 Korlantas Polri 执法局的资料,印尼 2019 年总共发生了 121,641 起道路事故。其中0.73%的事故是由于酒后驾驶造成的。因此,酒后驾驶事故导致的死亡人数不断上升,加速了对呼气分析仪的需求。
亚太地区呼吸分析仪市场概况
亚太地区分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。预计 2020 年至 2030 年期间,亚太地区因酗酒而导致的事故增加以及政府支持的增加导致呼吸分析仪设备的大量采用。由于中国人口饮酒量增加、酒后驾驶盛行率上升以及人们对使用呼气分析仪进行疾病诊断的认识不断增强,预计中国呼气分析仪市场将在2020年至2030年期间增长。饮酒是导致健康状况不佳的主要风险因素,每年导致全球超过 300 万人死亡。酒后驾驶引发的事故和酒精相关疾病的增加是中国人民面临的主要健康问题。根据《精神病学前沿》2020 年11 月发表的一篇文章,对2,229 名参与者进行了回顾性线上调查,以评估参与者在COVID-19 大流行之前和期间的饮酒行为以及他们目前的危险饮酒水平。调查发现,虽然大流行期间酒精消费量略有减少,但危险饮酒仍然很常见,特别是在大流行之前和期间比女性饮酒更多且从事危险行为的男性饮酒者中。
此外,为了解决中国长期存在的酒后驾车问题,需要有效执行法律和进行公众宣传活动。根据中国疾病预防控制中心消息,2020年10月,公共安全部交通管理局协同全国公安交通部门进行夜间综合检查。截至目前,共查处酒驾案件9,000余起,其中酒驾案件1,500余起。因此,由于上述因素,中国对酒精检测呼气分析仪的需求不断增长。此外,中国的研究人员正在开发用于检测人群疾病的呼吸分析仪。 PubMed 2023年9月发表的一篇文章中进行了一项研究,对比乳果糖呼气试验(LBT)和葡萄糖呼气试验(GBT)等呼气试验与空肠抽吸培养物在小肠细菌诊断中的诊断价值过度生长(SIBO)。因此,上述因素推动了中国呼气分析仪市场的成长。
亚太地区呼吸分析仪市场收入及 2030 年预测(百万美元)
亚太地区呼吸分析仪市场细分
亚太地区呼吸分析仪市场分为技术、应用、最终用户和国家。
根据技术,亚太呼吸分析仪市场分为燃料电池技术、红外线光谱、半导体感测器等。 2022年,燃料电池技术在亚太呼吸分析仪市场中占据最大份额。
根据应用,亚太地区呼吸分析仪市场分为酒精检测、医疗应用和药物滥用检测。 2022 年,医疗应用领域在亚太呼吸分析仪市场中占据最大份额。
根据最终用户,亚太地区呼吸分析仪市场分为医院和诊断中心、执法机构等。 2022年,医院和诊断中心细分市场在亚太呼吸分析仪市场中占据最大份额。
依国家/地区划分,亚太地区呼吸分析仪市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。 2022年,中国在亚太呼吸分析仪市场占据主导地位。
Thermo Fisher Scientific Inc、Alcolizer Pty Ltd、Dragerwerk AG & Co KGaA、Abbott Laboratories、Honeywell International Inc、KHN Solutions LLC、Bedfont Scientific Ltd 和 Intoximeters Inc 是亚太呼吸分析仪市场上的一些领先公司。
The Asia Pacific breath analyzer market is expected to grow from US$ 230.62 million in 2022 to US$ 834.77 million by 2030. It is estimated to grow at a CAGR of 17.4% from 2022 to 2030.
Growing Alcohol Consumption and Alcohol-Impaired Accidents Fuel to Asia Pacific Breath Analyzer Market
According to the World Data report published in 2022, the average consumption of alcohol across the world is 6.182 liters per person. The World Health Organization (WHO) reveals that excessive alcohol consumption results in 3 million deaths every year (representing 5.3% of the overall deaths worldwide), causing harm to the well-being and health of people. Additionally, 5.1% of the global burden of disease and injury caused to an individual due to alcohol drunken driving causes social and economic losses to individuals and society. Excessive alcohol consumption results in road traffic crashes and accidents.
In Australia, drunk driving accounts for about 30% of fatal collisions, with more than one in four drivers and passengers who die had blood alcohol content (BAC) levels above the permitted limit. According to police collision data, around one out of every three fatal crashes is caused by speeding. 163 individuals lost their lives in heavy vehicle accidents on the roads in 2021. This represents 15.4% of all traffic deaths. Also, according to data from the Korlantas Polri Directorate of Law Enforcement, there were 121,641 road accidents in total year 2019 in Indonesia. 0.73% of such incidents were the result of intoxicated driving. Therefore, the rising number of deaths due to accidents caused by drunken driving accelerates demand for breath analyzers.
Asia Pacific Breath Analyzer Market Overview
Asia Pacific region is segmented as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Asia Pacific region is dominated by growing accidents due to alcohol driven population and rising government support resulting in high adoption of breath analyzer devices for the forecast period 2020-2030. The breath analyzer market in China is expected to grow during 2020-2030 owing to increasing consumption of alcohol among the Chinese population, rising prevalence of alcohol-impaired driving, and growing awareness about the use of breath analyzers for disease diagnosis. Alcohol consumption is a leading risk factor for poor health and is responsible for over three million deaths worldwide annually. Accidents due to alcohol-impaired driving and rising alcohol-associated disorders are major health concerns for the Chinese population. According to an article published by Frontiers in Psychiatry in November 2020, a retrospective online survey was conducted on a sample of 2,229 participants to assess the drinking behaviors of the participants before and during the COVID-19 pandemic and their current levels of hazardous drinking. The survey found that while there was a slight reduction in alcohol consumption during the pandemic, hazardous drinking remained common, particularly among male drinkers who consumed more alcohol and engaged in riskier behavior than females both before and during the pandemic.
Additionally, to address the persistent problem of drinking and driving in China, effective enforcement of laws and public awareness campaigns are needed. According to the Chinese Center for Disease Control and Prevention, in October 2020, the Traffic Management Bureau of the Ministry of Public Security coordinated with public security traffic departments across the country to conduct comprehensive nighttime inspections. As a result, more than 9,000 cases of drinking and driving were detected and penalized, including over 1,500 cases of drunk driving. Therefore, the demand for breath analyzers for alcohol detection is growing in China due to above mentioned factors. Furthermore, researchers in China are engaged in the development of breath analyzers for the detection of disease among the population. In an article published by PubMed in September 2023, a study was carried out to contrast the diagnostic value of the breath tests such as lactulose breath test (LBT) and glucose breath test (GBT) with jejunal aspiration cultures in the diagnosis of small intestinal bacterial overgrowth (SIBO). Therefore, the factors mentioned above drive the breath analyzer market growth in China.
Asia Pacific Breath Analyzer Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Breath Analyzer Market Segmentation
The Asia Pacific breath analyzer market is segmented into technology, application, end user, and country.
Based on technology, the Asia Pacific breath analyzer market is segmented into fuel cell technology, infrared spectroscopy, semiconductor sensor, and others. The fuel cell technology held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on application, the Asia Pacific breath analyzer market is segmented into alcohol detection, medical applications, and drug abuse detection. The medical applications segment held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on end user, the Asia Pacific breath analyzer market is segmented into hospitals and diagnostic centers, law enforcement agencies, and others. The hospitals and diagnostic centers segment held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on country, the Asia Pacific breath analyzer market is segmented into China, Japan, India, South Korea, Australia, and the Rest Asia Pacific. China dominated the Asia Pacific breath analyzer market in 2022.
Thermo Fisher Scientific Inc, Alcolizer Pty Ltd, Dragerwerk AG & Co KGaA, Abbott Laboratories, Honeywell International Inc, KHN Solutions LLC, Bedfont Scientific Ltd, and Intoximeters Inc are some of the leading companies operating in the Asia Pacific breath analyzer market.